These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 12360682)
21. Loop diuretics enhance the secretion of prostacyclin in vitro, in healthy persons, and in patients with chronic heart failure. Liguori A; Casini A; Di Loreto M; Andreini I; Napoli C Eur J Clin Pharmacol; 1999 Apr; 55(2):117-24. PubMed ID: 10335906 [TBL] [Abstract][Full Text] [Related]
22. Clinical efficacy of torasemide, a new diuretic agent, in patients with acute heart failure: a double blind comparison with furosemide. Stroobandt R; Dodion L; Kesteloot H Arch Int Pharmacodyn Ther; 1982 Nov; 260(1):151-8. PubMed ID: 6762167 [TBL] [Abstract][Full Text] [Related]
23. Efficacy of oral torasemide in dogs with degenerative mitral valve disease and new onset congestive heart failure: The CARPODIEM study. Besche B; Blondel T; Guillot E; Garelli-Paar C; Oyama MA J Vet Intern Med; 2020 Sep; 34(5):1746-1758. PubMed ID: 32767627 [TBL] [Abstract][Full Text] [Related]
24. Pharmacoeconomic comparison of loop diuretics in the treatment of congestive heart failure. Heaton AH; Bryant J; Berman BN; Trotter JP Med Interface; 1996 Jan; 9(1):101-7. PubMed ID: 10153789 [TBL] [Abstract][Full Text] [Related]
25. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function. De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961 [TBL] [Abstract][Full Text] [Related]
26. Benefits and risks of torasemide in congestive heart failure and essential hypertension. Brater DC Drug Saf; 1996 Feb; 14(2):104-20. PubMed ID: 8852525 [TBL] [Abstract][Full Text] [Related]
27. Dose-dependent salidiuretic efficacy of torasemide in comparison to furosemide and placebo in advanced renal failure. Mourad G; Haecker W; Mion C Arzneimittelforschung; 1988 Jan; 38(1A):205-8. PubMed ID: 3285835 [TBL] [Abstract][Full Text] [Related]
29. Diuretic activity of torasemide and furosemide in chronic heart failure: a comparative double blind cross-over study. Scheen AJ; Vancrombreucq JC; Delarge J; Luyckx AS Eur J Clin Pharmacol; 1986; 31 Suppl():35-42. PubMed ID: 3780838 [TBL] [Abstract][Full Text] [Related]
30. Effects of loop diuretics on myocardial fibrosis and collagen type I turnover in chronic heart failure. López B; Querejeta R; González A; Sánchez E; Larman M; Díez J J Am Coll Cardiol; 2004 Jun; 43(11):2028-35. PubMed ID: 15172408 [TBL] [Abstract][Full Text] [Related]
31. Comparison of diuretic effects and pharmacokinetics of torasemide and furosemide after a single oral dose in patients with hydropically decompensated cirrhosis of the liver. Brunner G; von Bergmann K; Häcker W; von Möllendorff E Arzneimittelforschung; 1988 Jan; 38(1A):176-9. PubMed ID: 3285830 [TBL] [Abstract][Full Text] [Related]
32. Torasemide for the treatment of heart failure. Ishido H; Senzaki H Cardiovasc Hematol Disord Drug Targets; 2008 Jun; 8(2):127-32. PubMed ID: 18537599 [TBL] [Abstract][Full Text] [Related]
33. Tolerance of torasemide in cats with congestive heart failure: a retrospective study on 21 cases (2016-2019). Poissonnier C; Ghazal S; Passavin P; Alvarado MP; Lefort S; Trehiou-Sechi E; Saponaro V; Barbarino A; Delle Cave J; Marchal CR; Depré B; Vannucci E; Tissier R; Verwaerde P; Chetboul V BMC Vet Res; 2020 Sep; 16(1):339. PubMed ID: 32938442 [TBL] [Abstract][Full Text] [Related]